LOXL2 and neoplasm: Lysyl oxidase-like 2 (LOXL-2), a collagen-modifying enzyme, has been found to increase the stiffness of tumor tissue by modifying the ECM components in the TME in HCC, thereby promoting intrahepatic metastasis (Wong et al., 2014).